Lo.G protects medicines in transit
LIVE FROM TOTAL PROCESS & PACKAGING
The Lo.G protects products in transit with the help of a patented 360° impact absorbing buffer system, which ensures that contents are centrally cushioned and protected.
Lo.G packs are made from recycled HDPE plastic. As a nesting product, they offer weight, space and energy savings throughout the supply chain, from warehousing to point-of-sale, when compared with EPS block or foam protective packaging.
Plastique of Tunbridge Wells, Kent offers the Lo.G packaging in single piece ‘wrap-round and lock’ boxes or end cap formats to suit a variety of products.
The company also unveiled Paperlite rPET material developed by Flextrus of Sweden, which is an alternative to thermoformed plastic trays.
According to Plastique’s sales and marketing executive, Daryl Thompson, PaperLite can be used for packaging drugs or medical devices. The material, which looks and feels like paper, is based on FibreForm from Billerud and will run on existing form fill and seal lines. It is also FSC certified and has environmental advantages over thermoformed plastic trays.
PaperLite won the Packaging Innovation Award 2009 at the Scanpack exhibition in Gothenburg.
You may also like
Cell & Gene Therapy
Algen Biotechnologies partners with AstraZeneca in $555m deal to advance AI-driven drug discovery in immunology
Read moreAlgen Biotechnologies has entered a multi-target partnership with AstraZeneca to leverage its AI-powered AlgenBrain platform for identifying novel therapeutic targets in immunology, with the collaboration aimed at accelerating next-generation treatment discovery
Trending Articles
You may also like
Cell & Gene Therapy
Algen Biotechnologies partners with AstraZeneca in $555m deal to advance AI-driven drug discovery in immunology
Algen Biotechnologies has entered a multi-target partnership with AstraZeneca to leverage its AI-powered AlgenBrain platform for identifying novel therapeutic targets in immunology, with the collaboration aimed at accelerating next-generation treatment discovery
Analysis
Global biopharma faces talent shortages and regulatory uncertainty, Cytiva’s 2025 Global Biopharma Index finds
Cytiva’s latest Global Biopharma Index, surveying 1250 executives across 22 countries, reveals that while supply chain resilience is improving, talent shortages and policy instability are threatening growth across the biopharma sector
Microbiology
Boehringer Ingelheim and MOLCURE partner to accelerate AI-driven antibody discovery
Boehringer Ingelheim has entered a multi-year research agreement with MOLCURE to develop next-generation antibody therapeutics using MOLCURE's proprietary AI platform, combining machine learning and experimental data to streamline and enhance drug discovery
Manufacturing
Rentschler Biopharma expands services in Japan and South Korea ahead of BioProcess International Asia
Rentschler Biopharma will showcase its Rentschler Expression Platform and Development Services at BioProcess International Asia in Kyoto, underscoring its commitment to supporting biopharma partners across Japan and South Korea
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Decoding your personal health ecosystem: the power of microbiome diagnostics and nutraceuticals
People often talk about a “gut instinct” or a “gut feeling.” Until recently, though, actually discussing digestive health might have seemed unusual, suggests Christina Casén, Senior Vice President, Clinical and Medical Affairs at Genetic Analysis AS
Hi Tech Manufacturing
A new era in rheometry with Anton Paar’s next-generation MCR series
Building on its industry-leading legacy in rheometry, Anton Paar has unveiled its next generation of modular compact rheometers (MCRs), setting new benchmarks for precision, speed, intelligence, and adaptability in material characterisation